Factors affecting therapeutic placebo response rates in patients with irritable bowel syndrome

被引：10
作者：
Enck, P
Klosterhalfen, S
Kruis, W
机构：
[1] Univ Hosp Tubingen, Dept Internal Med 6, D-72072 Tubingen, Germany
[2] Univ Hosp Dusseldorf, Dusseldorf, Germany
[3] Evangel Krankenhaus Koln Kalk, Cologne, Germany
来源：
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY | 2005年 / 2卷 / 08期
关键词：
dosing frequency; intervention frequency; irritable bowel syndrome; placebo response;
D O I：
10.1038/ncpgasthep0237
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：354 / 355
页数：2
相关论文
共 6 条
[1]   Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome [J].
Chey, WD ;
Chey, WY ;
Heath, AT ;
Dukes, GE ;
Carter, EG ;
Northcutt, A ;
Ameen, VZ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (11) :2195-2203
[2]   The placebo response in functional bowel disorders: perspectives and putative mechanisms [J].
Enck, P ;
Klosterhalfen, S .
NEUROGASTROENTEROLOGY AND MOTILITY, 2005, 17 (03) :325-331
[3]   Quantification of the placebo response in ulcerative colitis [J].
Ilnyckyj, A ;
Shanahan, F ;
Anton, PA ;
Cheang, M ;
Bernstein, CN .
GASTROENTEROLOGY, 1997, 112 (06) :1854-1858
[4]   Meta-analysis: Can we mix apples and oranges? [J].
Moayyedi, P .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2297-2301
[5]   The placebo effect in irritable bowel syndrome trials: a meta-analysis [J].
Patel, SM ;
Stason, WB ;
Legedza, A ;
Ock, SM ;
Kaptchuk, TJ ;
Conboy, L ;
Canenguez, K ;
Park, JK ;
Kelly, E ;
Jacobson, E ;
Kerr, CE ;
Lembo, AJ .
NEUROGASTROENTEROLOGY AND MOTILITY, 2005, 17 (03) :332-340
[6]   Defining the predictors of the placebo response in irritable bowel syndrome [J].
Pitz, M ;
Cheang, M ;
Bernstein, CN .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (03) :237-247
1